Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2015-09-21 Report Publication Anno…
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Immediate Report
Report Publication Announcement Classification · 95% confidence The document is a short notification (1744 characters) from XTL Biopharmaceuticals Ltd. It explicitly states 'Attached hereto is a report on unaudited interim condensed consolidated financial statements as of June 30, 2015' and provides a filename 'XTL_6K_Q2_2015_isa.pdf'. Per the 'Menu vs Meal' rule, since this document is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement. H1 2015
2015-09-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XTL Biopharmaceuticals Ltd., with the SEC. It specifically states that it includes unaudited interim condensed consolidated financial statements as of June 30, 2015, and an Operating and Financial Review and Prospects for the same period. Form 6-K is used by foreign private issuers to report interim or other periodic financial information. The presence of unaudited interim financial statements and the Operating and Financial Review indicates this is an Interim / Quarterly Report. The document length is 2089 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2015-09-21 English
Immediate Report
Regulatory Filings
2015-09-10 Hebrew (modern)
Immediate Report
Report Publication Announcement Classification · 98% confidence The document is a short regulatory filing (1638 chars) from T L BIOPHARMACEUTICALS LTD, reported via MAGNA. The key sentence is: "Attached hereto is a report on *investor presentation.*" followed by a filename containing 'Presentation'. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication of another report (like an investor presentation), it should be classified as a Report Publication Announcement (RPA). The specific report being announced is an Investor Presentation (IP), but the filing itself is the announcement of that publication.
2015-09-10 English
FORM 6-K
Investor Presentation Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XTL Biopharmaceuticals Ltd., with the SEC. It states that an updated investor presentation was made available on the company's website and is attached as Exhibit 99.1. The document itself is short (1949 characters) and primarily serves to announce the availability of the investor presentation rather than containing the presentation or detailed financial data itself. According to the 'Menu vs Meal' rule, such a document is an announcement of a report rather than the report itself. Therefore, the appropriate classification is Investor Presentation (IP). The confidence is high because the document explicitly mentions the investor presentation and includes it as an exhibit.
2015-09-10 English
Immediate Report
Regulatory Filings
2015-09-02 Hebrew (modern)

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.